Company / PP&E (Net)
Insulet Corporation PP&E (Net) History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$599.9M
FY2022
5-year range
$536.5M / $599.9M
FY2018-FY2022
Trend
+11.8%
vs FY2021
Sector context
#46 of 135
Health Care
What the data says
At $600M, Insulet Corporation's pp&e (net) ranks #46 of 135 in the Health Care sector. PP&E (Net) has increased for 6 consecutive years, from $45M in FY2016 to $600M in FY2022.
Based on SEC 10-K filings.
$600M in FY2022 with a 5-year CAGR of +40.9%.
Improved from $479M to $600M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +40.9%
- 10-Year CAGR
- -
Sector benchmark
#46 of 135 in Health CareTop 34% of 135This company $599.9M Sector average $1.4B
▼
-56.0% below sector average
Key checks
Key Insights
- Insulet Corporation's pp&e (net) has grown for 6 consecutive years.
- 5-year CAGR of +40.9%, indicating consistent growth.
- In FY2022, pp&e (net) increased 11.8% year-over-year.
- Ranks #46 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $599.9M | +11.8% |
| FY2021 | $536.5M | +12.1% |
| FY2020 | $478.7M | +19.9% |
| FY2019 | $399.4M | +54.6% |
| FY2018 | $258.4M | +139.6% |
| FY2017 | $107.9M | +141.0% |
| FY2016 | $44.8M | +7.1% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026